Report Description Table of Contents How Are Rising Cerebrovascular Disease Cases and Neurovascular Imaging Procedures Shaping the Cerebral Angiography Market? – (Updated On: 9th-Nov-2026) According to Strategic Market Research, the Global Cerebral Angiography Market was valued at USD 760.0 million in 2025 and is projected to reach USD 1.23 billion by 2032, expanding at a CAGR of 7.1% during 2026–2032. The projected USD 470.0 million increase in annual market revenue is supported by cerebral aneurysm evaluation, diagnosis of abnormal brain blood vessels, angiography-guided neurovascular interventions, and investment in specialized imaging systems. Digital subtraction angiography (DSA) remains important for detailed cerebrovascular examination, while CT angiography (CTA) and MR angiography (MRA) provide additional noninvasive diagnostic options. Cerebral angiography procedure utilization continues to demonstrate the importance of specialized vascular imaging in neurovascular care. A 2024 U.S. Medicare study reported 83,199 catheter-based cerebral angiography procedures, 33,481 CTA examinations, and 52,703 MRA examinations in 2020, highlighting the continued clinical use of catheter angiography alongside noninvasive imaging. Brain aneurysm diagnosis remains an important application for cerebral angiography. According to the Brain Aneurysm Foundation, approximately 6.8 million Americans have an unruptured brain aneurysm, while around 30,000 aneurysm ruptures occur annually. Cerebral angiography helps doctors examine aneurysms, plan treatment, and monitor patients after procedures. The 2026 clinical guidelines also support its use in selected patients following aneurysm treatment. Cerebral arteriovenous malformations (AVMs) support the use of angiography-guided treatment. A 2025 U.S. study reported 8,935 AVM-related admissions involving endovascular embolization alone, representing 18.4% of 48,495 admissions studied through 2022. Cerebral angiography helps doctors identify abnormal brain blood vessels and guide treatment, supporting its use in specialized neurovascular hospitals. Subarachnoid hemorrhage diagnosis requires detailed examination of brain blood vessels. The 2026 Society of NeuroInterventional Surgery guidelines recommend catheter angiography in selected patients when the source of brain bleeding remains unclear. Doctors may examine six major cerebral vessels to identify abnormalities and plan treatment. This supports the continued use of cerebral angiography in emergency neurovascular care. Recent cerebral angiography procedure volumes highlight the commercial importance of specialized neurovascular imaging. A 2024 study published in the Journal of NeuroInterventional Surgery reported 465 diagnostic cerebral angiography procedures performed between August 2023 and January 2024, covering brain aneurysm assessment, post-treatment follow-up, arterial narrowing, and vascular malformations. Separately, a 2026 clinical audit published in the British Journal of Surgery documented 206 neurovascular procedures between April and October 2025, including 175 diagnostic digital subtraction angiography (DSA) procedures. These recent hospital-level figures demonstrate the continued clinical use of cerebral angiography for diagnosis and follow-up, supporting activity involving imaging systems, diagnostic catheters, contrast agents, and associated services. New neuroangiography equipment launches are strengthening competition among global imaging manufacturers. In August 2025, Philips introduced its Azurion Neuro Biplane system in Thailand, following its global debut in 2024. The system combines 2D and 3D vascular imaging for neurovascular diagnosis and minimally invasive treatment, including aneurysm procedures and stroke interventions. Philips also identified its Neuro Biplane release and Azurion R3 platform among the imaging innovations highlighted in its 2026 Diagnosis and Treatment investor presentation. These developments indicate continued manufacturer investment in specialized neuroangiography equipment, with competition increasingly centered on imaging quality, procedural efficiency, and integrated neurovascular treatment capabilities. The Cerebral Angiography Market is supported by the growing use of neurovascular imaging for brain aneurysms, stroke assessment, arteriovenous malformations (AVMs), and intracranial arterial disorders. Increasing use of catheter-based angiography for diagnosis, treatment planning, and follow-up examinations is strengthening opportunities for advanced cerebral imaging systems. Manufacturers with established neurovascular imaging portfolios, angiography equipment, and strong relationships with specialized stroke and neurosurgical centers are positioned to benefit from continued market expansion through 2032. Which Cerebral Angiography Segments Lead the Market, and Which Are Expanding the Fastest? By Imaging Modality: Detailed DSA Assessment and Rapid CT Imaging Serve Different Clinical Needs Leading Segment – Digital Subtraction Angiography (DSA) Digital Subtraction Angiography (DSA) accounted for an estimated 48% market share, valued at USD 364.80 million in 2025, and is projected to grow at a CAGR of 6.50% during 2026–2032. DSA remains a gold-standard imaging technique for evaluating complex cerebrovascular conditions, including brain aneurysms, arteriovenous malformations, and arterial blockages. Its established role in stroke assessment, cerebral vascular diagnosis, and image-guided neurovascular procedures continues to support its widespread use across specialized hospitals and neurovascular centers. Fastest-Growing Segment – CT Angiography (CTA) CT Angiography (CTA) accounts for an estimated 32% share of the global Cerebral Angiography Market, valued at USD 243.20 million in 2025, and is projected to register the fastest CAGR of 8.10% during 2026–2032. CTA is widely used for rapid, minimally invasive evaluation of cerebral blood vessels, supporting the detection of brain aneurysms, arterial blockages, and vascular abnormalities. Its ability to provide detailed vascular images and support timely stroke assessment strengthens its importance in emergency departments, hospitals, and specialized neurological imaging centers. By Procedure Type: Diagnostic Imaging Sustains Procedure Volume as Catheter-Based Treatment Expands Leading Segment – Diagnostic Cerebral Angiography Diagnostic procedures dominate the Cerebral Angiography Market, accounting for an estimated 62% market share, valued at USD 471.20 million in 2025, and are projected to grow at a CAGR of 6.00% during 2026–2032. Diagnostic cerebral angiography, particularly digital subtraction angiography (DSA), remains a gold-standard imaging procedure for detailed examination of blood vessels in the brain, head, and neck. Its clinical importance in identifying cerebral aneurysms, vascular malformations, arterial narrowing, and stroke-related abnormalities supports continued utilization across hospitals and specialized neurological centers. Fastest-Growing Segment – Interventional Cerebral Angiography Interventional procedures accounted for an estimated 38% of the global Cerebral Angiography Market, valued at USD 288.80 million in 2025, and are projected to register the fastest CAGR of 8.70% during 2026–2032. Interventional cerebral angiography supports minimally invasive treatment of vascular abnormalities within the brain, including cerebral aneurysms, arteriovenous malformations, and narrowed blood vessels. Growing use of catheter-based interventions, particularly aneurysm coiling, intracranial stenting, and embolization procedures, is strengthening the role of cerebral angiography in neurovascular treatment and supporting continued market expansion. By Application: Aneurysm Planning and Emergency Stroke Care Shape Imaging Use Leading Segment – Cerebral Aneurysms Cerebral aneurysms account for an estimated 32% share of the Global Cerebral Angiography Market, valued at USD 243.20 million in 2025, and are projected to grow at a CAGR of 7.20% during 2026–2032. Cerebral angiography plays an important role in identifying aneurysms, assessing their size and location, and guiding minimally invasive treatments such as coiling and flow diversion. Increasing use of digital subtraction angiography (DSA) for treatment planning, intervention, and follow-up examinations supports continued market growth. Fastest-Growing Segment – Ischemic Stroke Ischemic stroke accounts for an estimated 29% share of the global cerebral angiography market, valued at USD 220.40 million in 2025, and is projected to register the fastest CAGR of 8.20% during 2026–2032. Cerebral angiography plays an important role in evaluating blocked cerebral arteries, identifying the location of vascular obstructions, and guiding stroke treatment. Increasing use of angiography during emergency stroke assessment and endovascular procedures is supporting market growth, particularly as hospitals expand access to specialized stroke care and minimally invasive interventions. By End User: Hospital Stroke Services and Specialty Centers Expand Neurovascular Imaging Leading Segment – Hospitals Hospitals dominate the Cerebral Angiography Market, accounting for an estimated 68% market share, valued at USD 516.80 million in 2025, with a projected CAGR of 6.80% during 2026–2032. Hospitals remain the primary centers for cerebral angiography procedures, particularly for diagnosing brain aneurysms, arterial blockages, and cerebrovascular disorders. The availability of specialized neurovascular imaging facilities, experienced interventional neuroradiologists, and comprehensive stroke care services supports the continued expansion of cerebral angiography procedures across major hospitals and specialized neurological centers worldwide. Fastest-Growing Segment – Specialty Neurology and Neurovascular Centers Specialty neurology and neurovascular centers account for an estimated 12% of the global Cerebral Angiography Market, valued at USD 91.20 million in 2025, and are projected to register the fastest CAGR of 9.40% during 2026–2032. Specialized centers play an important role in diagnosing cerebral aneurysms, arteriovenous malformations, and cerebrovascular disorders through cerebral angiography. Increasing availability of dedicated neurovascular imaging services, expansion of outpatient diagnostic facilities, and growing use of cerebral angiography for stroke evaluation are supporting growth across specialty centers. By Geography: Established North American Stroke Services Meet Wider Imaging Access in Asia-Pacific Leading Region – North America North America holds a leading position in the Cerebral Angiography Market, accounting for an estimated 38% market share, valued at USD 288.80 million in 2025, with a projected CAGR of 6.20% during 2026–2032. The region benefits from widespread use of cerebral angiography in specialized neurological centers for diagnosing complex cerebrovascular conditions and guiding minimally invasive treatments. Increasing stroke care services, advanced neurovascular imaging facilities, and growing use of angiography during aneurysm treatment and other endovascular procedures continue to support regional market expansion. Fastest-Growing Region – Asia-Pacific Asia-Pacific accounts for an estimated 25% of the global Cerebral Angiography Market, valued at USD 190.00 million in 2025, and is projected to register the fastest regional CAGR of 8.80% during 2026–2032. Growth is supported by increasing diagnosis and treatment of cerebrovascular conditions, particularly stroke, brain aneurysms, and vascular malformations. Expanding neurovascular care facilities, improving access to specialized diagnostic imaging, and greater availability of cerebral angiography procedures across China, India, Japan, and South Korea are strengthening the region’s market outlook. What Are the Key Clinical Applications of Cerebral Angiography? Cerebral Aneurysm Diagnosis and Treatment: Cerebral angiography helps identify aneurysms, assess their location and shape, and examine surrounding blood vessels. It provides detailed vascular information for treatment planning, particularly in complex aneurysms requiring endovascular coiling, flow diversion, or surgical evaluation. Digital Subtraction Angiography (DSA) remains important for detailed assessment and imaging guidance during aneurysm treatment. Ischemic Stroke Evaluation and Intervention: Cerebral angiography plays an essential role in identifying blocked cerebral arteries and supporting emergency stroke treatment. CT Angiography (CTA) enables rapid assessment of arterial occlusions, while catheter-based angiography provides imaging guidance during mechanical thrombectomy. These applications are particularly important in comprehensive stroke centers treating patients with large-vessel occlusions. Arteriovenous Malformations (AVMs): Cerebral angiography supports the diagnosis and assessment of abnormal connections between arteries and veins in the brain. It helps specialists understand the location, size, and blood supply of AVMs, providing information for treatment planning. DSA is particularly valuable when evaluating complex vascular anatomy before embolization, surgery, or radiosurgery. Intracranial Stenosis and Atherosclerosis: Cerebral angiography helps evaluate narrowing of arteries supplying the brain, particularly in patients with suspected cerebrovascular disease or recurrent neurological symptoms. CTA and MRA are commonly used for initial vascular assessment, while DSA may provide additional information in selected cases requiring detailed evaluation or intervention. Cerebral Vasospasm Management: Cerebral angiography supports the identification and treatment of cerebral vasospasm, particularly following aneurysmal subarachnoid hemorrhage. Catheter-based imaging helps specialists assess affected vessels and guide selected endovascular treatments. Devices such as the FDA-cleared NeVa VS provide additional treatment options for severe symptomatic cerebral vasospasm. Brain Tumor and Other Cerebrovascular Assessments: Cerebral angiography is used in selected brain tumor cases to evaluate blood supply and support planning for surgery or preoperative embolization. It also assists in assessing vascular abnormalities associated with vasculitis and other complex cerebrovascular conditions. Its clinical value is particularly important when detailed vascular information can influence treatment selection and procedural safety. Which Companies Are Leading Cerebral Angiography Innovation and Neurovascular Imaging? Siemens Healthineers AG: ARTIS icono Supports Neurovascular Diagnosis and Intervention Siemens Healthineers is a prominent manufacturer of cerebral angiography equipment, offering the ARTIS icono platform for neurovascular diagnosis and interventions. Its systems support stroke treatment, cerebral aneurysm assessment, and arteriovenous malformation evaluation. The company reports that its syngo DynaCT Multiphase application can visualize cerebral collateral vessels at 10 time points within 60 seconds, supporting detailed vascular assessment during neurointerventional procedures. Its angiography portfolio strengthens its position in specialized neurological hospitals and interventional imaging centers. GE HealthCare Technologies Inc. – Allia and Revolution CT Support Vascular Imaging GE HealthCare is an established medical imaging manufacturer offering Allia image-guided systems and Revolution CT platforms for vascular imaging and interventional care. Its technologies support cerebral vascular examinations, stroke assessment, and image-guided procedures. The Allia IGS portfolio includes IGS 3, IGS 5, and IGS 7 configurations, reflecting the company's range of interventional imaging solutions. Its CT and angiography portfolios provide opportunities across hospital stroke services and advanced neurovascular imaging facilities. Other Important Companies: Koninklijke Philips N.V.: Introduced its Azurion Neuro Biplane system in February 2024, offering advanced 2D and 3D imaging for stroke treatment, cerebral aneurysm procedures, and other neurovascular interventions. Canon Medical Systems Corporation: Offers Alphenix angiography systems and Aquilion CT platforms for cerebral vascular imaging, with its integrated Alphenix 4D CT solutions supporting selected neurovascular and interventional applications. Analyst Commentary: How Will Clinical Validation and Hospital Adoption Shape AI in Cardiology? AI in cardiology is creating strong commercial opportunities in automated ECG analysis, cardiac imaging, arrhythmia detection, and heart failure monitoring. Clinical validation, regulatory approvals, hospital adoption, and integration with existing cardiac diagnostic systems will be key factors shaping market growth and competitive positioning. Cerebral Angiography Market Report Coverage Table Report Attribute Details Forecast Period 2026 – 2032 Market Size Value in 2025 USD 760.0 Million Revenue Forecast in 2032 USD 1.23 Billion Overall Growth Rate CAGR of 7.1% (2026 – 2032) Base Year for Estimation 2025 Historical Data 2019 – 2024 Unit USD Million/Billion, CAGR (2026 – 2032) Segmentation By Imaging Modality, By Procedure Type, By Application, By End User, By Geography By Imaging Modality Digital Subtraction Angiography, CT Angiography, MR Angiography By Procedure Type Diagnostic Cerebral Angiography, Interventional Cerebral Angiography By Application Cerebral Aneurysms, Ischemic Stroke, Arteriovenous Malformations, Intracranial Stenosis, Other Cerebrovascular Disorders By End User Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Specialty Neurology and Neurovascular Centers By Region North America, Europe, Asia-Pacific, Latin America, Middle East & Africa Country Scope U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Brazil, Mexico, Saudi Arabia, UAE, South Africa Market Drivers Demand for cerebral aneurysm evaluation and post-treatment follow-up, diagnosis of vascular malformations, angiography-guided neurovascular interventions, and investment in specialized imaging systems Customization Option Available upon request Frequently Asked Question About This Report Q1. What factors are driving growth across the Cerebral Angiography Market? A1. Growth is supported by rising neurovascular imaging procedures, aneurysm evaluation, stroke assessment, arteriovenous malformation diagnosis, and expanding use of angiography-guided interventions. Q2. What imaging trends are shaping the industry? A2. The industry is moving toward advanced digital subtraction angiography, CT angiography, MR angiography, and specialized neuroangiography systems. CTA is projected to record the fastest imaging-modality CAGR of 8.10% during 2026–2032. Q3. Which procedure type offers the strongest growth opportunity in the market? A3. Interventional cerebral angiography is projected to record the fastest procedure CAGR of 8.70% during 2026–2032. Expanding use in thrombectomy, aneurysm treatment, embolization, and other image-guided procedures is supporting growth. Q4. Which clinical application is expected to expand the fastest? A4. Ischemic stroke is projected to record the fastest application CAGR of 8.20% during 2026–2032. Greater use of vascular imaging for emergency assessment and endovascular stroke treatment is strengthening adoption. Q5. Which end-user category represents the fastest-growing opportunity? A5. Specialty neurology and neurovascular centers are projected to record the fastest end-user CAGR of 9.40% during 2026–2032. Expansion of dedicated neurovascular services and specialized imaging capabilities is supporting growth. Q6. Which region is expected to record the fastest growth in the industry? A6. Asia-Pacific is projected to record the fastest regional CAGR of 8.80% during 2026–2032. Growth is supported by expanding stroke treatment services, specialized neurovascular facilities, and increasing access to cerebral angiography in China, India, Japan, and South Korea. Q7. What commercial opportunities are emerging from new neuroangiography technologies? A7. New biplane angiography systems and integrated neurovascular imaging platforms are creating opportunities in stroke treatment, aneurysm procedures, and specialized intervention centers. Manufacturers are competing through advanced imaging capabilities and integrated procedural workflows. Sources: U.S. Medicare – 83,199 Catheter Angiography Services, 33,481 CTA Exams, and 52,703 MRA Exams in 2020. NIH PubMed Central – Medicare Cerebral Angiography Utilization and Reimbursement Study Brain Aneurysm Foundation – An Estimated 6.8 Million Americans Have an Unruptured Brain Aneurysm. Brain Aneurysm Foundation – U.S. Brain Aneurysm Statistics U.S. Cerebral AVM Study – 8,935 of 48,495 Admissions Involved Endovascular Embolization Alone. NIH PubMed Central – U.S. Cerebral AVM Admissions and Endovascular Treatment SNIS and NICE – Catheter Angiography Has a Defined Role in Selected Cases of Subarachnoid Hemorrhage. SNIS – 2026 Diagnostic Cerebral Angiography Guidelines · NICE – Subarachnoid Hemorrhage Diagnostic Recommendations Hospital-Level Procedure Volumes – 465 Diagnostic Cerebral Angiograms in One Review and 175 Diagnostic DSA Procedures in a Separate Audit. Journal of NeuroInterventional Surgery – Review of 465 Diagnostic Cerebral Angiograms · British Journal of Surgery – 2026 Cerebral Angiography Audit Philips – Azurion Neuro Biplane Launched Globally in 2024 and in Thailand in August 2025. Philips – Thailand Neuro Biplane Launch · Philips – 2026 Diagnosis and Treatment Investor Presentation Siemens Healthineers – ARTIS icono Can Visualize Cerebral Collateral Vessels at 10 Time Points Within 60 Seconds. Siemens Healthineers – ARTIS icono for Neurointerventions GE HealthCare and Canon Medical – Commercial Platforms for Neurovascular Imaging. GE HealthCare – Allia Image-Guided Systems · GE HealthCare – Stroke Imaging Solutions · Canon Medical – Alphenix Neurovascular Applications U.S. FDA – NeVa VS Received Humanitarian Device Exemption Approval on September 9, 2022. FDA – NeVa VS Approval and Indication U.S. ARPA-H – Awarded Philips North America Up to USD 33.7 Million for Image-Guided Robotic Stroke Care. ARPA-H – A-RISE Stroke Endovascular Care Award · Philips – 2026 Third-Quarter Results Table of Contents - Global Cerebral Angiography Market Report (2026–2032) Executive Summary Market Overview Market Attractiveness by Imaging Modality, Procedure Type, Application, End User, and Region Strategic Insights from Key Executives (CXO Perspective) Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Summary of Market Segmentation by Imaging Modality, Procedure Type, Application, End User, and Region Market Share Analysis Leading Players by Revenue and Market Share Market Share Analysis by Imaging Modality, Procedure Type, Application, and End User Investment Opportunities in the Cerebral Angiography Market Key Developments and Innovations in Neurovascular Imaging Systems New Neuroangiography Equipment Launches and Platform Upgrades High-Growth Segments for Investment Opportunities in Digital Subtraction Angiography, CT Angiography, MR Angiography, and Image-Guided Neurovascular Interventions Investment Opportunities in Stroke Assessment, Cerebral Aneurysm Diagnosis, and AVM Treatment Planning Developments in Biplane Imaging, Advanced Vascular Visualization, and Integrated Neurovascular Treatment Systems Market Introduction Definition and Scope of the Study Market Structure and Key Findings Overview of Top Investment Pockets Clinical Importance of Cerebral Angiography in Cerebrovascular Disease Diagnosis and Neurovascular Intervention Role of Cerebral Angiography in Brain Aneurysm Evaluation, Ischemic Stroke Assessment, AVM Diagnosis, and Intracranial Arterial Disorders Catheter-Based Cerebral Angiography and Noninvasive Neurovascular Imaging Overview Research Methodology Research Process Overview Primary and Secondary Research Approaches Market Size Estimation and Forecasting Techniques Data Triangulation and Segment-Level Forecasting Approach Historical Market Assessment (2019–2024) Base Year Market Validation (2025) Forecast Modeling and Market Projection (2026–2032) Market Dynamics Key Market Drivers Challenges and Restraints Impacting Growth Emerging Opportunities for Stakeholders Impact of Clinical Guidelines and Public Health Factors Growing Cerebrovascular Disease Burden and Demand for Specialized Neurovascular Imaging Increasing Use of Cerebral Angiography for Aneurysm Diagnosis, Stroke Assessment, and AVM Treatment Planning Role of Angiography-Guided Neurovascular Interventions and Specialized Imaging Systems in Market Expansion Advancements in Digital Subtraction Angiography, CT Angiography, and MR Angiography Hospital Investment in Biplane Imaging Systems and Integrated Neurovascular Treatment Platforms Global Cerebral Angiography Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Imaging Modality: Digital Subtraction Angiography (DSA) CT Angiography (CTA) MR Angiography (MRA) Market Analysis by Procedure Type: Diagnostic Cerebral Angiography Interventional Cerebral Angiography Market Analysis by Application: Cerebral Aneurysms Ischemic Stroke Arteriovenous Malformations (AVMs) Intracranial Stenosis Other Cerebrovascular Disorders Market Analysis by End User: Hospitals Diagnostic Imaging Centers Ambulatory Surgical Centers (ASCs) Specialty Neurology and Neurovascular Centers Market Analysis by Region: North America Europe Asia-Pacific Latin America Middle East & Africa Regional Market Analysis North America Cerebral Angiography Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Imaging Modality, Procedure Type, Application, and End User Country-Level Breakdown: United States Canada Neurovascular Imaging Infrastructure and Stroke Center Development Europe Cerebral Angiography Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Imaging Modality, Procedure Type, Application, and End User Country-Level Breakdown: Germany United Kingdom France Italy Rest of Europe Advanced Neurovascular Imaging and Interventional Care Adoption Asia-Pacific Cerebral Angiography Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Imaging Modality, Procedure Type, Application, and End User Country-Level Breakdown: China Japan South Korea India Rest of Asia-Pacific Expansion of Stroke Treatment Services and Specialized Neurovascular Imaging Facilities Latin America Cerebral Angiography Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Imaging Modality, Procedure Type, Application, and End User Country-Level Breakdown: Brazil Mexico Development of Specialized Neurological Imaging Services Middle East & Africa Cerebral Angiography Market Analysis Historical Market Size and Volume (2019–2024) Base Year Market Size Analysis (2025) Market Size and Volume Forecasts (2026–2032) Market Analysis by Imaging Modality, Procedure Type, Application, and End User Country-Level Breakdown: Saudi Arabia United Arab Emirates South Africa Rest of Middle East & Africa Expansion of Neurovascular Imaging Capabilities in Specialized Hospitals and Tertiary Care Centers Clinical Applications of Cerebral Angiography Cerebral Aneurysm Diagnosis and Treatment Planning Ischemic Stroke Evaluation and Endovascular Intervention Arteriovenous Malformation (AVM) Diagnosis and Treatment Planning Intracranial Stenosis and Atherosclerosis Assessment Cerebral Vasospasm Diagnosis and Management Brain Tumor and Other Cerebrovascular Assessments Post-Treatment Neurovascular Follow-Up and Vascular Monitoring Competitive Intelligence and Benchmarking Leading Key Players: Siemens Healthineers AG GE HealthCare Technologies Inc. Koninklijke Philips N.V. Canon Medical Systems Corporation Shimadzu Corporation Ziehm Imaging GmbH Carestream Health United Imaging Healthcare Co., Ltd. Competitive Landscape and Strategic Insights Benchmarking Based on Imaging Quality, Procedural Efficiency, Neurovascular Imaging Capabilities, Product Availability, and Regional Presence Neuroangiography Equipment Portfolio Analysis Biplane Imaging System and Integrated Neurovascular Platform Positioning Digital Subtraction Angiography and Advanced Vascular Visualization Technologies CT Angiography and MR Angiography Portfolio Positioning Product Launches and Technology Developments During 2024–2026 Philips Azurion Neuro Biplane Global Debut (2024) Philips Azurion Neuro Biplane Introduction in Thailand (August 2025) Philips Neuro Biplane and Azurion R3 Developments Highlighted in Its 2026 Investor Presentation Clinical Guidelines and Neurovascular Imaging Developments (2026) Appendix Abbreviations and Terminologies Used in the Report References and Sources Clinical and Procedure Volume References (2020–2025) Clinical Guidelines and Research Publications (2024–2026) Market Definitions and Segmentation Scope Historical Data Coverage (2019–2024) Base Year Definitions and Assumptions (2025) Forecast Methodology and Assumptions (2026–2032) List of Tables Market Size by Imaging Modality, Procedure Type, Application, End User, and Region (2026–2032) Historical Market Size and Volume (2019–2024), Base Year Market Size Analysis (2025), and Forecast (2026–2032) Regional Market Breakdown by Imaging Modality, Procedure Type, Application, and End User Country-Level Market Analysis Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Clinical Cerebral Angiography, CTA, and MRA Procedure Utilization (2020) AVM-Related Admissions and Endovascular Embolization Analysis Through 2022 Diagnostic Cerebral Angiography Procedure Analysis (2023–2024) Neurovascular Procedure and Diagnostic DSA Audit Analysis (2025) Competitive Benchmarking of Leading Cerebral Angiography Equipment Manufacturers Neuroangiography Equipment Launches and Technology Developments (2024–2026) Clinical Guidelines and Cerebral Angiography Applications (2026) List of Figures Market Drivers, Challenges, Opportunities, and Restraints Global Cerebral Angiography Market Overview and Regional Market Snapshot Competitive Landscape by Market Share Growth Strategies Adopted by Key Players Market Share by Imaging Modality, Procedure Type, Application, and End User (2025 vs. 2032) Regional Market Comparison Across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa Global Cerebral Angiography Ecosystem and Value Chain Analysis Clinical Applications Across Cerebral Aneurysms, Ischemic Stroke, AVMs, and Intracranial Stenosis Digital Subtraction Angiography, CT Angiography, and MR Angiography Technology Overview Neuroangiography Equipment and Biplane Imaging Innovation Timeline (2024–2026)